SARS

Disease caused by severe acute respiratory syndrome coronavirus

SARS ▸ Facts ▸ Comments ▸ News ▸ Videos

Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the virus SARS-CoV-1, the first identified strain of the SARS-related coronavirus. The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak. In 2004, Xue Wu Zhang and Yee Leng Yap found that the Spike 2 (S2) protein of SARS is structurally similar to HIV-1 gp41 subunit, suggesting an analogous membrane fusion mechanism between the two. In the 2010s, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.

0 shares	Share Tweet Save Post Send


Covid-19 HORROR: India Cross 7,000 Cases \| New Variant FOUND \| WHO Warns Of Global Rise India has crossed 7,000 active COVID-19 cases, with Kerala reporting the highest spike and three new deaths. The XFG variant, a sub-lineage of Omicron with strong immune evasion, has been detected.. Credit: Oneindia Duration: 03:29Published 2 weeks ago

You Might Like

How dangerous is new variant of Covid-19 NB.1.8.1? Here's what you need to know as cases spike in India In India, NB.1.8.1, a new sub-variant of COVID-19, has been detected. In April, its sample was gathered and sequenced. However, the SARS-CoV-2 samples that were sequenced in India in the last few weeks.. DNA - Published on May 26, 2025
JN.1 not expected to spread as existing Covid-19 vaccine will work: Ex-ICMR DG The JN.1 variant of the SARS-COV-2 virus is not expected to spread widely in India. Existing Covid-19 vaccines and mask-wearing in crowded places should be sufficient to combat it. The government is.. IndiaTimes - Published on December 27, 2023
Evidence of viral resistance to Covid-19 drug Paxlovid found A new research provided evidence of viral resistance to Paxlovid among SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug could soon become less effective in.. IndiaTimes - Published on March 30, 2023

Vaccination halves risk of long Covid, study shows Being vaccinated against the SARS-CoV-2 virus halves people's risk of developing long Covid, according to the largest study of its kind. The research, published in the journal JAMA Internal Medicine,.. IndiaTimes - Published on March 24, 2023
India gets first nasal Covid vaccine: How it can be the 'game changer' Centre on Thursday launched India's first nasal Covid-19 vaccine iNCOVACC. Bharat Biotech's Incovacc received government approval for use as a booster dose in the country-wide mass inouclation program... IndiaTimes - Published on January 26, 2023